Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hesham Elhalawani

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Radiology. Artificial Intelligence|June 17, 2021
Are Artificial Intelligence Challenges Becoming Radiology's New "Bee's Knees"?Hesham Elhalawani, Raymond Mak
Chemotherapy|August 26, 2015
Proteinuria in Patients with Solid Tumors Treated with Ramucirumab: A Systematic Review and Meta-AnalysisOmar Abdel-Rahman, Hesham ElHalawani
Expert Opinion on Drug Safety|August 28, 2015
Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysisOmar Abdel-Rahman, Hesham ElHalawani
Therapeutics and Clinical Risk Management|August 8, 2015
Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancersHesham ElHalawani, Omar Abdel-Rahman
Critical Reviews in Oncology/Hematology|May 1, 2016
Risk of cardiovascular adverse events in patients with solid tumors treated with ramucirumab: A meta analysis and summary of other VEGF targeted agentsOmar Abdel-Rahman, Hesham ElHalawani
Future Oncology (London, England)|October 1, 2015
Risk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysisOmar Abdel-Rahman, Hesham ElHalawani
Expert Opinion on Drug Safety|September 23, 2014
Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concernsOmar Abdel-Rahman, Hesham ElHalawani
Future Oncology (London, England)|March 26, 2015
Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysisOmar Abdel-Rahman, Hesham Elhalawani
Future Oncology (London, England)|February 4, 2016
S-1-based regimens for locally advanced/metastatic non-small-cell lung cancer: a meta-analysisOmar Abdel-Rahman, Hesham ElHalawani
Clinical Genitourinary Cancer|February 13, 2017
Risk of Distinctive Hair Changes Associated With Pazopanib in Patients With Renal Cell Carcinoma (RCC) Versus Patients Without RCC: A Comparative Systematic Review and Meta-analysisHesham Elhalawani, Muhammad Heiba, Omar Abdel-Rahman
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Radiology. Artificial Intelligence|June 17, 2021
Are Artificial Intelligence Challenges Becoming Radiology's New "Bee's Knees"?Hesham Elhalawani, Raymond Mak
Chemotherapy|August 26, 2015
Proteinuria in Patients with Solid Tumors Treated with Ramucirumab: A Systematic Review and Meta-AnalysisOmar Abdel-Rahman, Hesham ElHalawani
Expert Opinion on Drug Safety|August 28, 2015
Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysisOmar Abdel-Rahman, Hesham ElHalawani
Therapeutics and Clinical Risk Management|August 8, 2015
Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancersHesham ElHalawani, Omar Abdel-Rahman
Critical Reviews in Oncology/Hematology|May 1, 2016
Risk of cardiovascular adverse events in patients with solid tumors treated with ramucirumab: A meta analysis and summary of other VEGF targeted agentsOmar Abdel-Rahman, Hesham ElHalawani
Future Oncology (London, England)|October 1, 2015
Risk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysisOmar Abdel-Rahman, Hesham ElHalawani
Expert Opinion on Drug Safety|September 23, 2014
Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concernsOmar Abdel-Rahman, Hesham ElHalawani
Future Oncology (London, England)|March 26, 2015
Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysisOmar Abdel-Rahman, Hesham Elhalawani
Future Oncology (London, England)|February 4, 2016
S-1-based regimens for locally advanced/metastatic non-small-cell lung cancer: a meta-analysisOmar Abdel-Rahman, Hesham ElHalawani
Clinical Genitourinary Cancer|February 13, 2017
Risk of Distinctive Hair Changes Associated With Pazopanib in Patients With Renal Cell Carcinoma (RCC) Versus Patients Without RCC: A Comparative Systematic Review and Meta-analysisHesham Elhalawani, Muhammad Heiba, Omar Abdel-Rahman
Pageof 9